American Century Companies’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.1K Sell
11,650
-136,436
-92% -$1.04M ﹤0.01% 2786
2025
Q4
$1.44M Buy
148,086
+8,350
+6% +$71K ﹤0.01% 2203
2025
Q3
$585K Buy
139,736
+6,625
+5% +$42.3K ﹤0.01% 2466
2025
Q2
$1.24M Sell
133,111
-132
-0.1% -$1.15K ﹤0.01% 2206
2025
Q1
$1.3M Buy
133,243
+21,393
+19% +$265K ﹤0.01% 2155
2024
Q4
$1.35M Buy
111,850
+27,259
+32% +$331K ﹤0.01% 2155
2024
Q3
$927K Buy
84,591
+33,806
+67% +$343K ﹤0.01% 2269
2024
Q2
$457K Buy
50,785
+7,587
+18% +$52.9K ﹤0.01% 2476
2024
Q1
$353K Buy
43,198
+10,332
+31% +$84.7K ﹤0.01% 2576
2023
Q4
$277K Buy
32,866
+2,417
+8% +$28K ﹤0.01% 2601
2023
Q3
$521K Buy
30,449
+7,703
+34% +$151K ﹤0.01% 2253
2023
Q2
$528K Buy
22,746
+7,809
+52% +$153K ﹤0.01% 2199
2023
Q1
$261K Buy
14,937
+4,553
+44% +$108K ﹤0.01% 2345
2022
Q4
$282K Buy
+10,384
New +$216K ﹤0.01% 2238

Other funds holding REPL

American Century Companies's REPL Position: Q1 2026 in Review

American Century Companies reduced its Replimune Group (REPL) stake by 92% in Q1 2026, selling an estimated $1.04M and leaving 11,650 shares worth $89.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

American Century Companies first reported a position in REPL in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.44M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • American Century Companies held 11,650 shares of Replimune Group worth $89.1K as of Q1 2026.
  • American Century Companies sold 136,436 Replimune Group shares in Q1 2026, an estimated $1.04M.
  • Replimune Group made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2786 holding.
  • American Century Companies first reported a position in Replimune Group in Q4 2022 and has held it in 14 quarters since.
  • American Century Companies's Replimune Group position peaked at $1.44M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.